Valuation: Implantica AG

Market Cap 1.49B 1.71B 1.41B 1.28B 2.4B 164B 2.41B 16.89B 6.52B 83.54B 6.43B 6.29B 269B P/E 2026 *
-17.6x
P/E 2027 * -14.3x
Enterprise Value 1.47B 1.68B 1.38B 1.26B 2.35B 161B 2.36B 16.57B 6.4B 81.97B 6.31B 6.17B 264B EV / Sales 2026 *
427x
EV / Sales 2027 * 163x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day-1.65%
1 week-2.30%
Current month-1.00%
1 month+8.36%
3 months-4.18%
6 months+46.26%
Current year+18.96%
1 week 59
Extreme 59
62.4
1 month 53.2
Extreme 53.2
80.3
Current year 38
Extreme 38
80.3
1 year 38
Extreme 38
80.3
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
103.2
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Director/Board Member 71 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/31/26 Buy

Chairman

28,135 0.0484%
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 Sell

Chief Financial Officer

17,100 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%-2.30%-18.13%+191.44% 1.75B
-0.40%-0.04%+23.22%+21.11% 12.56B
-1.05%+0.77%+11.94%+16.93% 6.62B
-1.09%-3.16% - - 6.2B
-0.21%+2.66%+23.70%+10.27% 5.59B
-1.53%-1.17%-20.99%+35.65% 5.06B
+0.38%+3.39%-31.74%-24.86% 3.88B
-0.18%+7.61%+28.38%-11.32% 1.95B
-1.95%+2.06%+45.86%-17.74% 1.61B
-2.21%+3.49%-21.60%+33.09% 1.38B
Average -0.99%+0.72%+4.52%+28.29% 4.66B
Weighted average by Cap. -0.76%+0.12%+8.46%+21.00%

Financials

2026 *2027 *
Net sales 3.43M 3.94M 3.24M 2.94M 5.52M 378M 5.54M 38.84M 14.99M 192M 14.79M 14.46M 618M 9.14M 10.49M 8.63M 7.84M 14.69M 1.01B 14.75M 103M 39.91M 512M 39.4M 38.52M 1.65B
Net income -20.78M -23.83M -19.62M -17.81M -33.38M -2.29B -33.52M -235M -90.68M -1.16B -89.5M -87.52M -3.74B -25.61M -29.37M -24.18M -21.96M -41.14M -2.82B -41.31M -290M -112M -1.43B -110M -108M -4.61B
Net Debt -28.02M -32.14M -26.46M -24.03M -45.02M -3.08B -45.21M -317M -122M -1.57B -121M -118M -5.04B -1.71M -1.96M -1.61M -1.46M -2.74M -188M -2.75M -19.31M -7.45M -95.5M -7.35M -7.19M -307M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
26-09-18 SEK 59.60 -1.65% 43,540
26-09-17 SEK 60.60 +0.17% 55,125
26-09-16 SEK 60.50 -0.82% 51,248
26-09-15 SEK 61.00 0.00% 49,271
26-09-14 SEK 61.00 0.00% 53,178
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.269EUR
Average target price
8.141EUR
Spread / Average Target
+54.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!